Scrip
Biogen Idec reports sixth case of PML with Tysabri in 12 months
21 April 2009
Katie McQue
A sixth case of progressive multifocal leucoencephalopathy (PML) in the past 12 months has been reported in a patient taking
Biogen Idec's multiple sclerosis drug Tysabri (natalizumab).
The case was confirmed on April 15th – a day before the Massachusetts-based firm's first-quarter earnings conference...
Please Login to read the full article.
21 April 2009
Katie McQue
The case was confirmed on April 15th – a day before the Massachusetts-based firm's first-quarter earnings conference...
Please Login to read the full article.
RELATED CONTENT
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
